MYMETICS Corporation Ropes in Dendreon Corporation (DNDN), KPCB Vets as New CEO and Board Members to Restart Vaccine Developer
4/11/2012 7:48:45 AM
More...
|
MYMETICS Corporation Reclaims Innovative Intra-Nasal Influenza Vaccine
10/4/2011 8:09:23 AM
More...
|
MYMETICS Corporation Publishes Data From Groundbreaking HIV Vaccine Study
2/15/2011 8:39:40 AM
More...
|
MYMETICS Corporation HIV Vaccine Shows Strong Preliminary Phase I Data
11/30/2010 9:46:02 AM
More...
|
MYMETICS Corporation Secures New Patent for Virosome Based Vaccines
11/29/2010 9:44:52 AM
More...
|
Vivalis Signs New Eb66 Research License With MYMETICS Corporation
9/28/2010 11:11:21 AM
More...
|
MYMETICS Corporation's Novel HIV Vaccine to Begin New National Institutes of Health (NIH)-Funded Study at University of California, Davis (UCD)
9/13/2010 11:55:13 AM
More...
|
MYMETICS Corporation' Respiratory Syncytial Virus (RSV) Vaccine Protects From Viral Challenge in Pre-Clinical Study
6/28/2010 10:06:01 AM
More...
|
MYMETICS Corporation's Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania
6/17/2010 9:00:34 AM
More...
|
MYMETICS Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
1/19/2010 8:54:15 AM
More...
|
|